title: Regenerated hair cells in the European starling: are they more resistant to kanamycin ototoxicity than original hair cells?
abstract: Previous work from our laboratory [Marean et al. (1993) Hear. Res. 71, 125-136] has shown that a 10 day dose of 200 mg/kg/day kanamycin produced damage to the basal 34% of the starling basilar papilla. We also observed that repeating the dosing schedule following a 4 month survival period resulted in significantly less damage to the regenerated auditory epithelium. The present study investigated whether or not this apparent resistance was the result of a tendency for regenerated hair cells to be less susceptible to kanamycin ototoxicity, or if other, systemic factors may be involved. Eight European starlings were given subcutaneous injections of 200 mg/kg/day kanamycin for 10 days. Serum levels of kanamycin were measured at the time of sacrifice for all birds, and the basilar papillae of all birds were examined by scanning electron microscopy (SEM). Two of these birds (Group 1) were sacrificed immediately following the dosing period. Two of the birds were allowed to survive for 60 days (Group 2). Two of the birds were redosed with 200 mg/kg/day for 10 days after 60 days survival (Group 3). Finally, two birds were redosed with 250 mg/kg/day until serum levels of kanamycin were the same as Group 1 when sacrificed (> 9 micrograms/ml). The SEM results showed that the regenerated auditory epithelium of the birds dosed a second time sustained less damage compared to previously untreated ears, even though the dosing regimen was the same (Group 3 versus Group 1). The regenerated auditory epithelium of birds dosed a second time sustained the same damage as previously untreated animals when the dosage was increased to attain similar serum levels (Group 4 versus Group 1). These results suggest metabolic changes occur in the starling in response to the initial dose of kanamycin which do not necessarily involve changes in hair cell resistance to ototoxicity.
authors.affiliation: Department of Speech and Hearing Sciences, University of Washington, Seattle 98195, USA.
authors.forename: G C
authors.initials: GC
authors.lastname: Marean
authors.forename: D
authors.initials: D
authors.lastname: Cunningham
authors.forename: J M
authors.initials: JM
authors.lastname: Burt
authors.forename: M D
authors.initials: MD
authors.lastname: Beecher
authors.forename: E W
authors.initials: EW
authors.lastname: Rubel
mesh_terms: D000818:Animals; D001489:Basilar Membrane / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D001717:Birds; D002470:Cell Survival; D004305:Dose-Response Relationship, Drug; D004848:Epithelium / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D006198:Hair Cells, Auditory / Q000187:drug effects* / Q000502:physiology* / Q000648:ultrastructure; D007279:Injections, Subcutaneous; D007612:Kanamycin / Q000008:administration & dosage / Q000097:blood / Q000633:toxicity*; D008855:Microscopy, Electron, Scanning; D012038:Regeneration
chemical_list: D007612:Kanamycin